2017 Issues   /   Other

Obesity Linked to Higher PC Mortality

USM By U.S. Medicine
March 10, 2017

Los Angeles — While, at the population level, obesity is associated with prostate cancer (PC) mortality, little information is available on how obesity affects long-term PC-specific outcomes after initial treatment, according to a study in the journal Prostate Cancer and Prostatic Diseases.1

A study team led by Cedars-Sinai Medical Center researchers with participation from VA researchers from Los Angeles, Durham, NC, and Augusta, GA, conducted a retrospective analysis of 4,268 radical prostatectomy patients within the Shared Equal Access Regional Cancer Hospital (SEARCH) database.

Examined were associations between body mass index (BMI) and PC-specific mortality (PCSM) as the primary outcome. Secondary outcomes included biochemical recurrence (BCR) and castration-resistant PC (CRPC). BMI was used as a continuous and categorical variable with normal defined as less than 25 kg/m2, overweight as 25–29.9 kg/m2 and obese as greater than 30 kg/m2.

With a median follow-up among all surviving men at 6.8 years, 1, 384 men developed BCR, 117 developed CRPC and 84 died from PC.

Initial results indicated that higher BMI was not associated with risk of PCSM, BCR and CRPC. When BMI was categorized, overweight, with a hazard ratio (HR) of 1.99, and obesity (HR 1.97) were significantly associated with PCSM but not with BCR or CRPC.

On multivariable analysis adjusting for both clinical and pathological features, results were little-changed, in that obesity and overweight were associated with higher risk of PCSM but not with BCR or CRPC, except that the association for overweight was no longer statistically significant.

“Overweight and obesity were associated with increased risk of PCSM after radical prostatectomy,” the study authors concluded. “If validated in larger studies with longer follow-up, obesity may be established as a potentially modifiable risk factor for PCSM.”

The study posited that the connection between BMI and higher PC death rates is because:

  • Obese men might be less-aggressively screened, leading to delayed detection.
  • PC can be more difficult to detect in obese men, including physical challenges in performing a digital rectal examination and lower PSA further contributing to delayed detection.
  • Obese men may receive less-aggressive and less-effective treatment.
  • Obese men are less likely to undergo radical prostatectomy (RP), which some studies have shown results in lower PC death rates, and obese men are more likely to have positive margins at surgery.
  1. Vidal AC, Howard LE, Sun SX, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Freedland SJ. Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Prostate Cancer Prostatic Dis. 2016 Oct 4. doi: 10.1038/pcan.2016.47. [Epub ahead of print] PubMed PMID: 27698439.

Related Articles

How Veterans Feel About Remote Management of Their Care

While implantable devices have shown promise in reducing rehospitalization for heart failure (HF), VA researchers sought to determine if options that are less expensive and non-invasive would have comparable results.

Legislation: Clinicians Must Be Involved in Formulary Design, Purchasing

Legislation to prevent VA from outsourcing creation of its drug formulary and to require more input from medical professions is being considered in Congress.


U.S. Medicine Recommends


More From department of veterans affairs

Department of Veterans Affairs (VA)

How Veterans Feel About Remote Management of Their Care

While implantable devices have shown promise in reducing rehospitalization for heart failure (HF), VA researchers sought to determine if options that are less expensive and non-invasive would have comparable results.

Department of Veterans Affairs (VA)

Legislation: Clinicians Must Be Involved in Formulary Design, Purchasing

Legislation to prevent VA from outsourcing creation of its drug formulary and to require more input from medical professions is being considered in Congress.

Department of Veterans Affairs (VA)

GAO: VA Needs Better Planning for ‘Complex’ Appeals System Overhaul

VA’s Consolidated Mail Outpatient Pharmacy (CMOP) in Charleston, SC. New legislation is seeking to increase clinician input into formulary decisionmaking. WASHINGTON — Legislation to prevent VA from outsourcing creation of its drug formulary and to... View Article

Department of Veterans Affairs (VA)

Community Providers Unprepared to Serve Veterans Under Choice Program

As the debate about increasing access for veterans to community-based provider heats up, a serious problem has emerged: Few providers outside the VA health system appear to be prepared to meet the unique challenges of the veteran population.

Department of Veterans Affairs (VA)

Former VA Secretary Nominee Claims Allegations Against Him Are False

Veterans’ groups expressed concern last month regarding a “lack of permanent leadership at the department,” after Rear Adm. Ronny L. Jackson, MD, withdrew his name from consideration as VA secretary amid anonymous allegations of misconduct.

Facebook Comment

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up